Skip to main content

Table 6 Wilcoxon sign-rank test was used to test the difference between pre-PP1M and Post-PP1M. Comparison of Indirect Costs Before and After Transition to PP1M

From: A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China

 

Caregiver care costs

Productivity costs

Indirect costs

pre-PP1M (¥)

3830±3260

11,767±8133

15,967±10,128

Post-PP1M (¥)

2141±4044

8137±8150

10,279±11,878

Difference

-44.10%

-30.85%

-35.62%

P

≤ 0.01

≤ 0.01

< 0.01